Introduction
In 1991, Washington State pharmacists were granted dependent prescriptive authority via collaborative drug therapy agreements with any practitioner licensed in the state of Washington authorized to prescribe legend drugs.
Collaborative drug therapy agreements (CDTAs) in accordance with the laws (RCW 18.64.011)¹ and regulations (WAC 246-863-100) 2 allow pharmacists prescriptive authority in various settings and for various purposes. There is no statutory authority to limit the pharmacists' prescriptive authority to any particular class of drugs or location of practice. The intent of the CDTA regulation is to increase the capacity and access to pharmaceutical care for the citizens of WA State so that health outcomes are improved.
A CDTA is a prepared, written guideline or protocol algorithm authorizing the pharmacist to include specific prescribing functions into their practice. The CDTA document may include prescribing for the management of disease states, medication refills, preventative health care, medication reviews and emergency situations.
Purpose
This paper provides a description of the current CDTA topics on file with the Washington State Department of Health credentialing department.
Having reviewed hundreds of CDTAs, it is possible to categorize the list into practice settings, noting that the CDTA itself could stand in any desired setting. This paper includes a sample of CDTAs, as not all of the protocols had expired and were in need of renewal.
Retail and Independent Pharmacy CDTAs
Immunization protocols include VFC (Vaccine for Children) 3 , adolescent and adult routine preventative care, travel shots and free vaccine for adults (VFA). VFA is an additional collaborative effort with Merck ® Vaccine and Sanofi® vaccine. Many hospital and clinic systems rely on a team of pharmacists to refill medications for system patients, as this popular protocol exists for most systems in Washington State.
As of July 1, 2014, the state of Kansas joined the other 48 states and Washington, D.C in a nationwide trend towards advancing the practice of pharmacists who wish to utilize their doctor of pharmacy (PharmD) degrees to improve drug therapy and healthy outcomes for their patients. 6 In contrast pharmacists in the UK under the National Health System have two avenues for prescriptive authority as supplementary prescribing (SP) introduced in 2003 or independent prescribing (IP) introduced in 2006. 7 Supplemental prescribing and collaborative drug therapy agreements are generally equivalent practices with American pharmacists moving to advance practice degrees and specialties as the health care system environment changes. The UK offers an advanced practice degree deemed the Masters Advanced Pharmacy Practice degree (PgDip/MSc) that makes a pharmacist qualified to be a Pharmacist Independent Prescriber. 8
Conclusion
The current practice of clinical pharmacists in the State of Washington reflects a professional practice at the level of dependent prescriptive authority. Pharmacists are valued members of a team of providers taking the role of medication specialist providers. Insurance companies recognize this value as prescriptions written by pharmacists are covered entities. Furthering pharmacist's credibility into prescribing can be supported by a comparable advanced master's degree offered to our UK counterparts.
For twenty three years, Washington State has recognized the value of pharmacist's interventions via the CDTA regulations.
There are approximately 6300 registered in-state pharmacists who also provide advanced patient-centered services such as coordination of medications during care transitions, medication management, comprehensive medication reviews with ongoing medication monitoring, chronic disease management, disease education, prevention and wellness services, and patient education. 9 For patients to achieve the full benefit of their medications, pharmacists must be part of the health care team as pharmacy practice advances from distributing pills to managing ills.
Further outcome research concerning the impact in patient care would be the next interesting step as pharmacists take responsibility for medication selection, monitoring and management.
